(CNN) — People looking to lose weight and lower their blood sugar may someday be able to get a single injection that turns their cells into tiny factories churning out a protein that is essentially the active ingredient in drugs like Ozempic, Wegovy, Zepbound and Mounjaro.
That’s the ambition of two biotech startups, New York-based RenBio and Fractyl Health in Massachusetts. Both companies have completed initial tests showing that their approaches work, at least in mice, and both have started tests in larger animals — pigs and monkeys — to see whether their gene therapies can work in larger animals.
With continued success and enough funding, they hope to bring the therapies to human patients — although it may take years more research to prove that their ideas work and are safe.
Newer G

WKOW 27

FOX 5 Atlanta Crime
WRDW-TV News 12 Crime
11Alive Crime
13WMAZ
Atlanta News First
WTVM News Leader 9
Tampa Bay Times Health